Lauppe, R., Nilsson, F. O. L., Fues Wahl, H., Lilja, M., Vikström, A., & Asanin, S. T. (2022). Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study. Acta Oncologica, 61(11), 1354–1361. https://doi.org/10.1080/0284186X.2022.2133972